Neoleukin Therapeutics (NLTX) Q4 2022 Earnings

20MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.3
-0.27
-0.24
-0.21

Details

Expected EPS
-0.21
Actual EPS
-0.24
Surprise EPS
-0.03
Surprise Percent
+14.29%

Description

Neoleukin Therapeutics (NLTX) has reported earnings of -0.24 per share for Q4 2022.

0 Comments

Share your thoughts